glioblastoma multiforme

News

TAE raises $40m to develop new targeted radiotherapy

Medtech firm TAE Life Sciences is developing a ground-breaking radiotherapy technology which will be able to treat hard-to-reach cancers with targeted beams.

Views & Analysis

Kick-starting innovation in Glioblastoma

Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?

News

Tocagen’s brain tumour candidate gets PRIME designation

An early-stage drug candidate for hard-to-treat brain tumours has been granted special ‘PRIME’ status by the European Medicines Agency.

TAE raises $40m to develop new targeted radiotherapy

Kick-starting innovation in Glioblastoma

Tocagen’s brain tumour candidate gets PRIME designation

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

glioblastoma multiforme

Editor's Picks